Back to Intellectual Property News
Morrison & Foerster Secures Jury Verdict for ICU Medical in Patent Infringement Case
Tuesday, December 21, 2010
San Francisco, CA -- Morrison & Foerster recently secured a jury verdict for ICU Medical, Inc. in a patent infringement case against RyMed Technologies, Inc. On December 17, 2010, an eight-person jury in the U.S. District Court of Delaware found that RyMed’s InVision Plus I.V. connector infringes two patents owned by ICU. The jury also found that ICU’s patents are valid.
“We are pleased that the jury confirmed the validity of ICU's patents and found infringement of those patents by RyMed," said Morrison & Foerster partner James Bennett, who was lead attorney for ICU in this case.
ICU develops, manufactures, and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. In July 2007, ICU filed a complaint against RyMed alleging that the InVision Plus I.V. connector infringes certain patents owned by ICU relating to ICU’s needle-free I.V. connector technology.
Along with Mr. Bennett, the Morrison & Foerster team included partners Karen Hagberg, Rory Radding and Kim Van Voorhis, as well as associates Katherine Nolan Stevaux, Daniel Zlatnik, and Diana Luo.
About MoFo
We are Morrison & Foerster — a global firm of exceptional credentials. Our clients include some of the largest financial institutions, investment banks, Fortune 100, technology and life science companies. We’ve been included on The American Lawyer’s A-List for seven straight years, and Fortune named us one of the “100 Best Companies to Work For.” Our lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger. This is MoFo.
Back to Intellectual Property News
